SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-mediated mesangial cell proliferation in vitro

American Journal of Pathology

Volumn 148, Issue 4, 1996, Pages 1153-1167

  Pichler, Raimund H ^a   Bassuk, James A ^b   Hugo, Christian ^a   Reed, May J ^b   Eng, Eudora ^a   Gordon, Katherine L ^a   Pippin, Jeffrey ^a   Alpers, Charles E ^b   Couser, William G ^a   Sage, E Helene ^b   Johnson, Richard J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEONECTIN; PLATELET DERIVED GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLOMERULOSCLEROSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MESANGIUM CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; RAT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, THY-1; CELLS, CULTURED; DNA REPLICATION; FIBROBLAST GROWTH FACTORS; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS; GROWTH INHIBITORS; MALE; MOLECULAR SEQUENCE DATA; OSTEONECTIN; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 9244265468     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Alpers CE, Hudkins KL, Gown AM, Johnson RJ. Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 1992, 41.1134-1142
2. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers C, Couser WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 1991, 40 477-488
3. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, Johnson RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992, 41:297-309
4. Floege J, Alpers CE, Burns MW, Pritzl P, Gordon K, Couser WG, Johnson RJ. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 1992, 66:485-497
5. Pesce CM, Striker LJ, Peten E, Elliot J, Striker GE Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone Lab Invest 1991, 65.601-605
6. Floege J, Eng E, Young B, Couser WG, Johnson RJ. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis Kidney Int 1993, 43 369-380
7. Johnson RJ, Raines E, Floege J, Yoshimura A, Pritzl P, Alpers CE, Ross R. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibodies to platelet-derived growth factor. J Exp Med 1992, 175:1413-1416
8. Floege J, Eng E, Young BA, Alpers CE, Barrett TB, Bowen-Pope DF, Johnson RJ Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats J Clin Invest 1993, 92:2952-2962
9. Floege J, Hugo C, Gordon K, Reilly M, Burg M, Reidy M, Couser WG, Johnson RJ Basic fibroblast growth factor (bFGF) mediates glomerular mesangial cell (MC) and endothelial cell proliferation in experimental mesangioproliferative nephritis (MesPGN). J Am Soc Nephrol 1995, 6:865
10. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J Mesangial cell apoptosis. the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994, 94:2105-2116
11. Reed MJ, Puolakkainen PA, Lane TF, Dickerson D, Bornstein P, Sage EH. Expression of SPARC and thrombospondin-1 in wound repair. immunolocalization and in situ hybridization J Histochem Cytochem 1993, 41.1467-1477
12. Lane TF, Sage EH: The biology of SPARC, a protein that modulates cell-matrix interactions FASEB J 1994, 8:163-173
13. Funk SE, Sage EH. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts J Cell Physiol 1993, 154: 53-63
14. Sage EH. Secretion of SPARC by endothelial cells transformed by polyoma middle T oncogene inhibits the growth of normal endothelial cells in vitro. Biochem Cell Biol 1992, 70 579-592
15. Hasselaar P, Sage EH: SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 1992, 49 272-283
16. 2+-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991, 88.2648-2652
17. Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH: The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDQF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 1992, 89:1281-1285
18. Adler S, Baker PJ, Johnson RJ, Ochi RF, Pritzl P, Couser WG: Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest 1986, 77:762-767
19. Wroblewski F, LaDue JS: Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 1955, 90:210
20. Bassuk JA, Baneyx F, Vernon R, Funk SE, Sage EH Expression of biologically active human SPARC in Escherichia coli. Arch Biochem Biophys 1996, 325 8-19
21. Hasselaar P, Loskutoff DJ, Sawdey M, Sage EH: SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells. J Biol Chem 1991, 266 13178-13184
22. Johnson RJ, Garcia RL, Pritzl P, Alpers CE: Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 1990, 136:369-374
23. ++-binding sites modulate cell shape J Cell Biol 1990, 111 3065-3076
24. Floege J, Alpers CE, Sage EH, Pritzl P, Gordon K, Johnson RJ, Couser WG Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo: expression of antiadhesive proteins and cytoskeletal changes Lab Invest 1992, 67:486-497
25. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzl P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. α-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991, 87.847-858
26. Laemmli UK. Cleavage of structural proteins during the assembly of the bacteriophage T4. Nature 1970, 227: 680-685
27. Floege J, Eng E, Lindner V, Alpers CE, Young BA, Reidy MA, Johnson RJ: Rat glomerular mesangial cells synthesize basic fibroblast growth factor release, up-regulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest 1992, 90: 2362-2369
28. Iruela-Arispe ML, Diglio CA, Sage EH. Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro. Arterioscler Thromb 1991, 11:805-815
29. Holland PWH, Harper SJ, McVey JH, Hogan BLM. In vivo expression of mRNA for the Ca-binding protein SPARC (osteonectin) revealed by in situ hybridization. J Cell Biol 1987, 105.473-482
30. Iida H, Seifert R, Alpers CE, Gronwald RG, Phillips PE, Pritzl P, Gordon K, Gown A, Ross R, Bowen Pope DF, Johnson RJ: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat Proc Nat Acad Sci USA 1991, 88:6560-6564
31. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE: The activated mesangtal cell: a glomerular "myofibroblast"? J Am Soc Nephrol 1992, 2:S190-197
32. Floege J, Eng E, Young BA, Johnson RJ. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int Suppl 1993, 39:S47-54
33. Yoshimura A, Gordon K, Alpers CE, Floege J, Pritzl P, Ross R, Couser WG, Bowen-Pope DF, Johnson RJ Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int 1991, 40.470-476
34. Johnson RJ, Lombardi D, Eng E, Gordon K, Alpers CE, Pritzl P, Floege J, Young B, Pippin J, Couser WG, Gabbiani G. Modulation of experimental mesangial proliferative nephritis by interferon-γ. Kidney Int 1995, 47 62-69
35. Mene P, Abboud HE, Dunn MJ. Regulation of human mesangial cell growth in culture by thromboxane A2 and prostacyclin. Kidney Int 1990, 38:232-239
36. MacKay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE: Transforming growth factor-β murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 1989, 83:1160-1167
37. Floege J, Eng E, Young BA, Couser WG, Johnson RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 1993, 43:369-380
38. Border WA, Okuda S, Nakamura T, Languino LR, Ruoslahti E: Role of TGF-β1 in experimental glomerulonephritis. Ciba Found Symp 1991, 157:178-189
39. Termine JD, Kleinman HK, Whitson SM, Conn KM, McGarvey ML, Martin GR: Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981, 25:99-105
40. Mayer U, Aumailley M, Mann K, Timpl R, Engel J: Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV. Eur J Biochem 1991, 198 141-150
41. Engel J, Taylor W, Paulsson M, Sage H, Hogan B Calcium binding domains and calcium-induced transition in SPARC (osteonectin/BM-40), an extracellular glycoprotein expressed in mineralized bone and non-mineralized tissues. Biochemistry 1987, 26:6958-6965
42. Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol 1994, 125.929-943
43. Yost JC, Sage EH: Specific interaction of SPARC with endothelial cells is mediated through a carboxyl-terminal sequence containing a calcium-binding EF hand J Biol Chem 1993, 268.25790-25796
44. Floege J, Johnson RJ, Alpers CE, Fatemi NS, Richardson CA, Gordon K, Couser WG: Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain Am J Pathol 1993, 142.637-650
45. 2+-dependent binding to the extracellular matrix. J Cell Biol 1989, 109.341-356
46. Murphy-Ullrich JE, Lightner VA, Aukhil I, Yan YZ, Erickson HP, Höök M: Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin J Cell Biol 1991, 115:1127-1136
47. Goldblum SE, Ding X, Funk SE, Sage EH: SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function Proc Natl Acad Sci USA 1994, 91:3448-3452
48. Lane TF, Iruela-Arispe ML, Sage EH: Regulation of gene expression by SPARC during angiogenesis in vitro; changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1. J Biol Chem 1992, 267:16736-16745